Graves Diseases Global Clinical Trials Review, H2, 2017

2017-08-30
Price :
Published : Aug-2017
No. of Pages : 69
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Graves Diseases to Hormonal Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Graves Diseases to Hormonal Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Graves Diseases Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profile Snapshots 32
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Source 69

List of Tables
Graves Diseases Therapeutics, Global, Clinical Trials by Region, 2017* 7
Graves Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Graves Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Graves Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Graves Diseases Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Graves Diseases Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Graves Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
Proportion of Graves Diseases to Hormonal Disorders Clinical Trials, G7 Countries (%), 2017* 15
Graves Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Graves Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Graves Diseases to Hormonal Disorders Clinical Trials, E7 Countries (%), 2017* 18
Graves Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Graves Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Graves Diseases Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Graves Diseases Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Graves Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Graves Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Graves Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Graves Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Graves Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Graves Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Graves Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31

List of Figures
Graves Diseases Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Graves Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Graves Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Graves Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Graves Diseases Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Graves Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
Proportion of Graves Diseases to Hormonal Disorders Clinical Trials, G7 Countries (%), 2017* 15
Graves Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Graves Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Graves Diseases to Hormonal Disorders Clinical Trials, E7 Countries (%), 2017* 18
Graves Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Graves Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Graves Diseases Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Graves Diseases Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Graves Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Graves Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Graves Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Graves Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Graves Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Graves Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Graves Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31
GlobalData Methodology 68
Filed in: Pharmaceutical
Publisher : GlobalData